Venkat Reddy
Amministratore Delegato presso Macrophage Pharma Ltd.
Profilo
Venkat Reddy was the founder of Advanced Proteome Therapeutics, Inc. (founded in 2016) where he served as the Chief Executive Officer from 2016 to 2017.
He currently holds the position of Chief Executive Officer at Macrophage Pharma Ltd.
since 2020, Chief Science Officer at General Inception Management LLC since 2022, and Board Member at Tavira Therapeutics since 2023.
Additionally, he is a Board of Director at Pharmacelera SL starting from 2023.
In his former positions, Dr. Reddy worked as a Senior Director at Pfizer Inc. from 2014 to 2016, Senior Director at Sanofi from 2013 to 2014, and Senior Vice President at Glenmark Pharmaceuticals Ltd.
from 2018 to 2019.
He obtained a doctorate degree from Ludwig-Maximilians-Universität München.
Posizioni attive di Venkat Reddy
| Società | Posizione | Inizio |
|---|---|---|
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Amministratore Delegato | 01/06/2021 |
Pharmacelera SL
 Pharmacelera SL Information Technology ServicesTechnology Services Pharmacelera SL engages in providing hardware and software solution services for pharm screen and pharmQSAR. Its products include pharmScreen, phramQSAP and phramaBox. The company was founded by Enric Herrero Abellanas and Enric Gibert Codina and is headquartered in Barcelona, Spain. | Direttore/Membro del Consiglio | 01/03/2023 |
General Inception
 General Inception Investment ManagersFinance General Inception Management LLC (General Inception Management) is a venture capital firm founded in 2020 by Vikram Chaudhery, Paul A. Conley and Jim Buzzitta. The firm is headquartered in San Francisco, California. | Corporate Officer/Principal | 01/02/2022 |
Precedenti posizioni note di Venkat Reddy
| Società | Posizione | Fine |
|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01/10/2019 |
Advanced Proteome Therapeutics, Inc.
 Advanced Proteome Therapeutics, Inc. BiotechnologyHealth Technology Part of Advanced Proteome Therapeutics Corp., Advanced Proteome Therapeutics Inc. is a company that has developed a proprietary approach for streamlining the production and targeted delivery of anti-cancer drugs to cancerous tumors. The company is based in Boston, MA. The company's work allows cancer drugs to be efficiently produced and delivered to cancerous tumors in a targeted fashion that doesn't destroy the patient's normal healthy cells indiscriminately. The benefit of targeted therapies, such as Advanced Proteome's approach, is their ability to home in on cancer cells while sparing healthy cells, thereby avoiding the nasty side effects of traditional chemotherapeutics. The CEO of the company is Benjamin Alexander Krantz. | Amministratore Delegato | 01/05/2017 |
| PFIZER, INC. | Direttore/Membro del Consiglio | 01/08/2016 |
| SANOFI | Direttore/Membro del Consiglio | 01/06/2014 |
Formazione di Venkat Reddy
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| SANOFI | Health Technology |
| GLENMARK PHARMACEUTICALS LIMITED | Health Technology |
| Aziende private | 4 |
|---|---|
Advanced Proteome Therapeutics, Inc.
Advanced Proteome Therapeutics, Inc. BiotechnologyHealth Technology Part of Advanced Proteome Therapeutics Corp., Advanced Proteome Therapeutics Inc. is a company that has developed a proprietary approach for streamlining the production and targeted delivery of anti-cancer drugs to cancerous tumors. The company is based in Boston, MA. The company's work allows cancer drugs to be efficiently produced and delivered to cancerous tumors in a targeted fashion that doesn't destroy the patient's normal healthy cells indiscriminately. The benefit of targeted therapies, such as Advanced Proteome's approach, is their ability to home in on cancer cells while sparing healthy cells, thereby avoiding the nasty side effects of traditional chemotherapeutics. The CEO of the company is Benjamin Alexander Krantz. | Health Technology |
Macrophage Pharma Ltd.
Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Health Technology |
Pharmacelera SL
Pharmacelera SL Information Technology ServicesTechnology Services Pharmacelera SL engages in providing hardware and software solution services for pharm screen and pharmQSAR. Its products include pharmScreen, phramQSAP and phramaBox. The company was founded by Enric Herrero Abellanas and Enric Gibert Codina and is headquartered in Barcelona, Spain. | Technology Services |
General Inception
General Inception Investment ManagersFinance General Inception Management LLC (General Inception Management) is a venture capital firm founded in 2020 by Vikram Chaudhery, Paul A. Conley and Jim Buzzitta. The firm is headquartered in San Francisco, California. | Finance |
- Borsa valori
- Insiders
- Venkat Reddy
